研究者業績

福原 隆宏

フクハラ タカヒロ  (Fukuhara Takahiro)

基本情報

所属
自治医科大学 医学部 耳鼻咽喉科学講座 准教授

研究者番号
80403418
J-GLOBAL ID
201801015724680955
researchmap会員ID
B000344651

学歴

 2

論文

 162

MISC

 14
  • Yukari Endo, Satoshi Kuwamoto, Takahito Ohira, Michiko Matsushita, Takahiro Matsushige, Takahiro Fukuhara, Shu Nakamoto, Kazuhiko Hayashi, Hiroyuki Kugoh, Yasuaki Hirooka
    Yonago acta medica 62(1) 67-76 2019年3月  
    Background: Adenoid cystic carcinoma (ACC) is a relatively rare malignant neoplasm that occurs in salivary glands and various other organs. Recent studies have revealed that a significant proportion of ACCs harbor gene alterations involving MYB or MYBL1 (mostly fusions with NFIB) in a mutually-exclusive manner. However, its clinical significance remains to be well-established. Methods: We investigated clinicopathological and molecular features of 36 ACCs with special emphasis on the significance of MYBL1 alterations. Reverse-transcription polymerase-chain reaction (RT-PCR) and fluorescence in-situ hybridization (FISH) were performed to detect MYB/MYBL1-NFIB fusions and MYBL1 alterations, respectively. Immunohistochemistry was performed to evaluate MYB expression in the tumors. The results were correlated with clinicopathological profiles of the patients. Results: RT-PCR revealed MYB-NFIB and MYBL1-NFIB fusions in 10 (27.8%) and 7 (19.4%) ACCs, respectively, in a mutually-exclusive manner. FISH for MYBL1 rearrangements was successfully performed in 11 cases, and the results were concordant with those of RT-PCR. Immunohistochemically, strong MYB expression was observed in 23 (63.9%) tumors, none of which showed MYBL1 alterations. Clinicopathologically, a trend of a better disease-specific survival was noted in patients with MYBL1 alterations than in those with MYB-NFIB fusions and/or strong MYB expression; however, the difference was not significant. Interestingly, we found tumors with MYBL1 alterations significantly frequently occurred in the mandibular regions (P = 0.012). Moreover, literature review revealed a similar tendency in a previous study. Conclusion: Our results suggest that there are some biological or etiological differences between ACCs with MYB and MYBL1 alterations. Moreover, the frequent occurrence of MYBL1-associated ACC in the mandibular regions suggests that MYB immunohistochemistry is less useful in diagnosing ACCs arising in these regions. Further studies are warranted to verify our findings.
  • 高森 稔弘, 伊澤 正一郎, 福原 隆宏, 三宅 成智, 石杉 卓也, 足立 良行, 今井 智登世, 佐藤 明美, 原 文子, 山本 一博, 本倉 徹
    けんさしつ (87別冊) 2018年6月  査読有り
  • 三宅成智, 福原隆宏, 藤原和典, 小山哲志, 堂西亮平, 木原智志, 吉岡佳奈, 竹内裕美
    日本頭頸部外科学会総会ならびに学術講演会プログラム・予稿集 28th 2018年  
  • 福原 隆宏, 藤原 和典, 三宅 成智, 片岡 英幸, 北野 博也
    頭頸部癌 41(1) 83-89 2015年4月  

共同研究・競争的資金等の研究課題

 5

産業財産権

 1